PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Werbeagentur & PR-Agentur co-operate

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Merger and New Name – Pharmaceutical Service Provider Diapharm Grows Together - German service providers for the pharmaceutical industry merge, trading under the new name Diapharm
Merger and New Name – Pharmaceutical Service Provider Diapharm Grows Together

 

NewswireToday - /newswire/ - Muenster, North Rhine-Westfalia, Germany, 2008/01/29 - German service providers for the pharmaceutical industry merge, trading under the new name Diapharm.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

From 1 February 2008 the Diapharm group of companies will operate under a new structure, with Diapharm International GmbH handling all the pharmaceutical service provider’s central customer management services. The specialist regulatory consultancy companies, Dr. Stefan Sandner GmbH in Münster and Dr. Kolkmann & Partner GmbH in Oldenburg, are merging to form Diapharm Regulatory Services GmbH. Both companies will keep their own premises. Starting in February, the group’s companies in Oldenburg and Lübeck specializing in clinical & user testing, biotechnology and analysis will also be trading under the single name Diapharm.

“We are changing to this more centralized corporate structure in response to our customers’ needs: areas of expertise are arranged more clearly and lines of communication are more transparent”, explains Dr. Stefan Sandner, Managing Director of Diapharm International GmbH. The core of the group is the specialist agency diapharm® which was founded in 1988. In 2007 the DiapharmGruppe companies achieved sales of more than 10 million euros.

Advice and service for medicinal and health products

Diapharm assists companies in the medicinal and health-product industries with all regulatory, medical and pharmaceutical matters relating to medicinal products, medical devices, food supplements, biocides and cosmetics. In addition to the headquarters, Diapharm International GmbH, Diapharm also consists of Diapharm Clinical Management GmbH in Oldenburg (formerly Beate Beime & Team), Diapharm Biotech GmbH in Lübeck (formerly Dr. Middeler et al. GmbH), Diapharm Analytics GmbH in Oldenburg (formerly Zentralinstitut Arzneimittelforschung GmbH) and Diapharm Regulatory Services GmbH (formerly Dr. Stefan Sandner GmbH and Dr. Kolkmann & Partner GmbH) in Oldenburg and Münster.

Dr. Ebeling & Assoc. GmbH in Hamburg and Hälsa Pharma GmbH in Lübeck will continue to be partners of Diapharm. The group is represented Europe-wide, with partners in France, the United Kingdom, Poland, Portugal, Slovenia, Spain, the Czech Republic and Hungary.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Werbeagentur & PR-Agentur co-operate

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Merger and New Name – Pharmaceutical Service Provider Diapharm Grows Together

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Christian Rieke - Co-Operate.net 
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Werbeagentur & PR-Agentur co-operate securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Werbeagentur & PR-Agentur co-operate / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
Sartorius Announces Expansion of Sartorius Stedim Cellca
Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  1Click Games





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)